RxDoctor Payments DataLook up a doctor →

William Kernodle, MD

Psychiatry · Richmond, VANPI 1699765024

Payments from drug & device makers

$14,122in general payments, 2019–2025

Across 908 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Johnson & Johnson$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Neurocrine Biosciences, Inc.$903
  • Sunovion Pharmaceuticals Inc.$761
  • plus $7K from 28 others

What the payments were for

  • Food & beverage$14,074100%
  • Education$490%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,122 in reported general payments places this provider in the 95th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$92,395
Medicare patients
204
Services billed
815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyvanseLisdexamfetamine Dimesylate12$7,437
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine252$6,871
Alprazolam778$6,650
Clonazepam960$6,056
Loreev XrLorazepam13$5,567
Lorazepam579$3,559
Trazodone Hcl354$2,037
Bupropion XlBupropion Hcl140$1,928
Fluoxetine Hcl426$1,733
Mirtazapine130$1,252
Diazepam202$1,244
Escitalopram Oxalate201$1,138
Doxepin Hcl60$886
Sertraline Hcl175$718
Aripiprazole29$688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$1,023$7,43712 claims
Almatica Pharma LLCLoreev Xr, Sertraline Hcl$421$6,285188 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →